A bi-institutional phase II study of hepatic arterial infusion (HAI) with floxuridine (FUDR) and dexamethasone (Dex) combined with systemic gemcitabine and oxaliplatin (GemOx) for unresectable intrahepatic cholangiocarcinoma (ICC).
Year: 2018
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Andrea Cercek, Nancy E. Kemeny, Thomas Boerner, Benjamin R. Tan, Joanne F. Chou, Mithat Gonen, Taryn Mary Boucher, Haley Hauser, Richard K. G. Do, Maeve Aine Lowery, Peter Kingham, Michael Ian D'Angelica, Jeffrey A. Drebin, Peter J. Allen, Neeta Vachharajani, Maria Majella Doyle, Ryan Fields, William G. Hawkins, William C. Chapman, William R. Jarnagin
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2892044757